PuSH - Publication Server of Helmholtz Zentrum München: The ferroptosis inducer erastin irreversibly inhibits system x<sub>c</sub>- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Sato, M.* ; Kusumi, R.* ; Hamashima, S.* ; Kobayashi, S.* ; Sasaki, S.* ; Komiyama, Y.* ; Izumikawa, T.* ; Conrad, M. ; Bannai, S.* ; Sato, H.*

The ferroptosis inducer erastin irreversibly inhibits system x_c- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.

Sci. Rep. 8:968 (2018)

Publ. Version/Full Text

Research data

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

System x c - was recently described as the most upstream node in a novel form of regulated necrotic cell death, called ferroptosis. In this context, the small molecule erastin was reported to target and inhibit system x c - , leading to cysteine starvation, glutathione depletion and consequently ferroptotic cell death. Although the inhibitory effect of erastin towards system x c - is well-documented, nothing is known about its mechanism of action. Therefore, we sought to interrogate in more detail the underlying mechanism of erastin's pro-ferroptotic effects. When comparing with some well-known inhibitors of system x c - , erastin was the most efficient inhibitor acting at low micromolar concentrations. Notably, only a very short exposure of cells with low erastin concentrations was sufficient to cause a strong and persistent inhibition of system x c - , causing glutathione depletion. These inhibitory effects towards system x c - did not involve cysteine modifications of the transporter. More importantly, short exposure of tumor cells with erastin strongly potentiated the cytotoxic effects of cisplatin to efficiently eradicate tumor cells. Hence, our data suggests that only a very short pre-treatment of erastin suffices to synergize with cisplatin to efficiently induce cancer cell death, findings that might guide us in the design of novel cancer treatment paradigms.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

4.122

1.245

115

129

PuSH - Publication Server of Helmholtz Zentrum München

The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.

The ferroptosis inducer erastin irreversibly inhibits system x_c- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells.